Phase 2 Study of Pomalidomide (CC-4047) Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain Tumors

Overview of attention for article published in Frontiers in oncology, June 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 20 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 6 X posts from 4 X users, with an upper bound of 11,157 followers.

Open Access UCL Research: Phase 2 Study of Pomalidomide (CC-4047) Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain Tumors https://t.co/f4v1irYQDr

05 Jul 2021

Reply Repost Favourite

Phase 2 Study of Pomalidomide (CC-4047) Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain Tumors https://t.co/KxraOwecnw

28 Jun 2021

Reply Repost Favourite

RT @FrontOncology: New article by Jason Fangusaro (@fangusaro), Katherine E. Warren (@theNCI), and colleagues outline a phase II study on t…

11 Jun 2021

Reply Repost Favourite

RT @FrontOncology: New article by Jason Fangusaro (@fangusaro), Katherine E. Warren (@theNCI), and colleagues outline a phase II study on t…

09 Jun 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.